- Suppliers
ADM 
Armor Pharma 
Asahi KASEI 
Ashland 
BASF 
Beneo 
Budenheim 
Captisol 
Croda 
DFE Pharma 
Excipio Chemicals 
Fuji Chemical 
Gattefossé 
Gangwal 
IOI Oleo 
Ingredient Pharm 
JRS Pharma 
Kerry 
KLK Oleo 
Lipoid 
Lubrizol Life Science Health 
MAGNESIA 
MEGGLE 
Nagase Viita 
Nordic Bioproducts 
Pfanstiehl 
pharm-a-spheres 
PMC Isochem 
Seppic 
ShinEtsu 
Sigachi 
SPI Pharma 
Südzucker 
Vikram Thermo 
Zerion Pharma
- Suppliers
ADM Armor Pharma Asahi KASEI Ashland BASF Beneo Budenheim Captisol Croda DFE Pharma Excipio Chemicals Fuji Chemical Gattefossé Gangwal IOI Oleo Ingredient Pharm JRS Pharma Kerry KLK Oleo Lipoid Lubrizol Life Science Health MAGNESIA MEGGLE Nagase Viita Nordic Bioproducts Pfanstiehl pharm-a-spheres PMC Isochem Seppic ShinEtsu Sigachi SPI Pharma Südzucker Vikram Thermo Zerion Pharma
Seppic is launching SEPINEO PRD 100, an innovative robust polymer designed for versatile topical drug dosage forms
Seppic is launching SEPINEOTM PRD 100
PRESS RELEASE
Paris, October 27, 2025: The dermo-pharmaceutical market, valued at over $21 billion, is experiencing significant growth 1 with a CAGR of over 11%, driven by increasing consumer and patients demand for advanced topical solutions. Formulators constantly face challenges: developing stable formulations, ensuring compatibility with different technologies, managing complex APIs, and facilitating patient compliance. It is within this landscape that Seppic introduces SEPINEOTM PRD 100.
This innovative polymer offers multifunctional properties, including thickening and texturizing, specifically designed for a wide variety of topical drug dosage forms, under challenging formulation conditions. It is specifically engineered to answer the pharmaceutical industry’s critical needs and meet formulators’ challenges.
SEPINEO™ PRD 100 delivers a transparent, rich, and velvety texture with a versatile viscosity profile, from sprayable to thick. This results in a highly desirable sensorial profile that facilitates patient compliance. For formulators, its pre-neutralized nature and excellent co-stabilizing properties streamline development by reducing processing steps and formulation attempts. This rheological profile, coupled with its unique texture, enables suitability for a wide range of innovative topical drug dosage forms like refined foams and sprayable solutions.
To address the challenges of developing stable topical drug dosage forms with challenging ingredients, SEPINEO™ PRD 100 provides a robust, stress-resistant solution that maintains stability even with stressful conditions, such as electrolyte and solvent/oil-rich environments, or in the presence of stressor APIs.
Guenolé LE CALVEZ, Marketing Director at Seppic, stated:
“Seppic is continuing its innovation strategy and investments in the dermo-pharmaceutical market with the launch of SEPINEO™ PRD 100. This product addresses recurring issues faced by our customers and complements our fl agship SEPINEO™ polymer range, thereby strengthening our position as a key player in this market.”
This new SEPINEO™ PRD 100 complies with the most stringent quality standards, has a US DMF Type IV, and Seppic’s Richmond facility based in Virginia USA holds an ISO 9001 certifi cation.
We had the chance at CPhI Frankfurt to get a short interview on the new SEPINEO™ PRD 100:
Read the original press release here
Source: SEPPIC, website Seppic is launching SEPINEO PRD 100, an innovative robust polymer designed for versatile topical drug dosage forms
If you have any questions or need a sample by SEPPIC, please feel free to contact us:
Related Posts
